DocGo Delivers Strong Q4 Results, Beating Revenue Expectations and Boosting 2026 Guidance
DocGo, a leading provider of virtual care and mobile health services, has reported a strong close to the year with revenue exceeding expectations in its fourth quarter earnings call. The company announced $74.9 million in revenue for the quarter, beating the top end of its guidance, despite an adjusted EBITDA loss of $11.6 million.
CEO Lee Bienstock attributed the revenue growth to new customer expansions and improved hiring rates, which have enabled DocGo to increase its 2026 revenue guidance to $290 million-$310 million, compared to a previous projection of $280 million-$300 million. The company's adjusted EBITDA loss is now expected to be $5-$10 million, down from the previously projected $15-$25 million.
The star performer in DocGo's portfolio was its virtual care offering, SteadyMD, which exceeded $8 million in revenue for the first time in its history. The company recorded $6.1 million of this revenue in the fourth quarter and reported a full year-over-year gross margin improvement from 30% to 37%. Additional gains are expected in 2026.
SteadyMD's impressive performance was driven by an increase in patient interactions, with over 4 million visits recorded for the full year 2025. This represents a significant jump from approximately 2.5 million patient interactions in 2024, which consisted of lab orders and synchronous and asynchronous telehealth visits.
DocGo's integration efforts remain on track, with plans to consolidate provider networks so that SteadyMD clinicians can provide care for patients across the company's mobile health offerings by the end of the second quarter. This move is expected to further boost revenue and drive growth in 2026.
The strong performance of SteadyMD has highlighted the potential for virtual care to transform the healthcare industry. As more people seek convenient, affordable, and high-quality care, DocGo's mobile health services are well-positioned to meet this demand.
Despite the challenges faced by the company in 2025, including costs associated with winding down migrant-related programs, DocGo's resilience and adaptability have enabled it to achieve a strong close to the year. With its increased revenue guidance and improved cost efficiency initiatives, the company is poised for growth in 2026.
The healthcare industry continues to evolve at an unprecedented pace, driven by technological innovation, changing consumer behavior, and shifting government policies. DocGo's focus on virtual care and mobile health services has positioned it as a leader in this space, and its strong Q4 results have reinforced its commitment to delivering high-quality, patient-centered care.
As the company looks ahead to 2026, investors and analysts will be closely watching its progress. With its improved revenue guidance and cost efficiency initiatives, DocGo is well-positioned to achieve significant growth in the coming year.
The company's commitment to innovation and customer satisfaction has been a key driver of its success. By continuing to invest in its virtual care offering and mobile health services, DocGo can maintain its position as a leader in the healthcare industry.
